Articles tagged with “oligonucleotide-pipeline”

GSK SiranBio Deal: SA-030 siRNA Cardiometabolic Strategy

Examine the May 2026 GSK-SiranBio licensing deal for SA-030. Learn how this ALK7-targeting siRNA advances GSK's cardiometabolic and oligonucleotide strategy.

40 min read

4/29/2026

gsk siranbio sa-030 sirna therapeutics alk7 cardiometabolic disease oligonucleotide pipeline biopharma licensing rna interference